1. Home
  2. NCEL vs UZX Comparison

NCEL vs UZX Comparison

Compare NCEL & UZX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewcelX Ltd. Ordinary Shares

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.66

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

UZX

Linkage Global Inc. Class A Ordinary Shares

N/A

Current Price

$1.01

Market Cap

15.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
NCEL
UZX
Founded
2008
2011
Country
Switzerland
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
15.8M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
NCEL
UZX
Price
$2.66
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.2K
★ 29.2K
Earning Date
09-18-2026
06-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$0.07
52 Week High
$5.12
$1.88

Technical Indicators

Market Signals
Indicator
NCEL
UZX
Relative Strength Index (RSI) 41.44 50.57
Support Level $1.95 $0.75
Resistance Level $3.32 $1.25
Average True Range (ATR) 0.34 0.09
MACD 0.00 -0.03
Stochastic Oscillator 20.51 32.28

Price Performance

Historical Comparison
NCEL
UZX

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

About UZX Linkage Global Inc. Class A Ordinary Shares

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: